K Pharma,Inc. (4896) Other
Market cap
¥8.8B
P/E ratio
-12.9x
K Pharma develops treatments for neurological diseases like ALS and Alzheimer's using iPS cell technology and regenerative medicine based on Keio University research.
| 2018/12 | 2019/10 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | - | -49.7 | 11.1 | -7.8 | -11.8 |
| Return on equity (%) | - | - | - | - | |||||
| Employees | 7 | 9 | 9 | 10 | 11 | 13 | 15 | 17 | 20 |